Neurological Associates

Pompano Beach, Florida 33060

0 studies enrolling now · 11 studies all time

What they study most

Central Neuropathic Pain, Clinically Isolated Syndrome, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis — Completed
• A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis — Completed
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed
• Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed